| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YJMCC.2012.11.006 |
| P698 | PubMed publication ID | 23178899 |
| P50 | author | Maria F. Gomez | Q57236613 |
| Ivar Sjaastad | Q65675496 | ||
| P2093 | author name string | Geir Christensen | |
| Cathrine R Carlson | |||
| Geir Florholmen | |||
| Ida G Lunde | |||
| Kate M Herum | |||
| Biljana Skrbic | |||
| Dina Behmen | |||
| P2860 | cites work | Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction | Q36370200 |
| Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis | Q36371664 | ||
| Emerging new drugs for scar reduction | Q36407401 | ||
| Mechanical induction of gene expression in connective tissue cells | Q37785159 | ||
| Transforming growth factor (TGF)-β signaling in cardiac remodeling. | Q37808014 | ||
| DSCR1 gene expression is dependent on NFATc1 during cardiac valve formation and colocalizes with anomalous organ development in trisomy 16 mice | Q40596613 | ||
| Adhesion signalling complexes | Q41864387 | ||
| Syndecan-4 modulates focal adhesion kinase phosphorylation | Q44043440 | ||
| Angiotensin II and norepinephrine activate specific calcineurin-dependent NFAT transcription factor isoforms in cardiomyocytes. | Q45970904 | ||
| Increased syndecan expression following myocardial infarction indicates a role in cardiac remodeling | Q48935393 | ||
| Syndecan-4 Deficiency Impairs Focal Adhesion Formation Only under Restricted Conditions | Q58211929 | ||
| Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy | Q73267718 | ||
| Molecular mechanisms of myocardial remodeling | Q77918078 | ||
| NFATc2 is a necessary mediator of calcineurin-dependent cardiac hypertrophy and heart failure | Q81269550 | ||
| Serum syndecan-4 is a novel biomarker for patients with chronic heart failure | Q83598067 | ||
| Syndecan-4 prevents cardiac rupture and dysfunction after myocardial infarction | Q83866038 | ||
| Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth | Q24309615 | ||
| Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells | Q24313011 | ||
| Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4 | Q24681644 | ||
| Syndecan-4 is essential for development of concentric myocardial hypertrophy via stretch-induced activation of the calcineurin-NFAT pathway | Q27311486 | ||
| A calcineurin-dependent transcriptional pathway for cardiac hypertrophy | Q28269300 | ||
| Force activates smooth muscle alpha-actin promoter activity through the Rho signaling pathway | Q28566405 | ||
| Myocardin: a component of a molecular switch for smooth muscle differentiation | Q28566619 | ||
| Syndecan-4 binding to the high affinity heparin-binding domain of fibronectin drives focal adhesion formation in fibroblasts | Q28576503 | ||
| Scleraxis and NFATc regulate the expression of the pro-alpha1(I) collagen gene in tendon fibroblasts | Q28592074 | ||
| Actin dynamics control SRF activity by regulation of its coactivator MAL | Q28646140 | ||
| Transmembrane signaling proteoglycans | Q30390527 | ||
| Integrative genomics identifies DSCR1 (RCAN1) as a novel NFAT-dependent mediator of phenotypic modulation in vascular smooth muscle cells | Q30433341 | ||
| Smoothelin is a specific marker for smooth muscle neoplasms of the gastrointestinal tract. | Q30934163 | ||
| NFAT and Osterix cooperatively regulate bone formation | Q31813054 | ||
| Defining the role of syndecan-4 in mechanotransduction using surface-modification approaches | Q33552237 | ||
| Inhibition of transforming growth factor-beta signaling induces left ventricular dilation and dysfunction in the pressure-overloaded heart | Q33656046 | ||
| Heparan sulfate chain valency controls syndecan-4 function in cell adhesion | Q33825117 | ||
| Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis | Q33895485 | ||
| Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy | Q33974366 | ||
| Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development | Q33975200 | ||
| Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction | Q34066752 | ||
| Exploring the neighborhood: adhesion-coupled cell mechanosensors. | Q34768683 | ||
| The role of modulatory calcineurin-interacting proteins in calcineurin signaling | Q35055274 | ||
| Matrix contraction by dermal fibroblasts requires transforming growth factor-beta/activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK: insights into pathological scarring in chronic fibrotic disease | Q35094477 | ||
| Reversibility of adverse, calcineurin-dependent cardiac remodeling | Q35189672 | ||
| Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation | Q35746732 | ||
| Interaction between NFκB and NFAT coordinates cardiac hypertrophy and pathological remodeling | Q35926510 | ||
| Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts | Q36232642 | ||
| The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. | Q36288284 | ||
| P304 | page(s) | 73-81 | |
| P577 | publication date | 2012-11-22 | |
| P1433 | published in | Journal of Molecular and Cellular Cardiology | Q2061932 |
| P1476 | title | Syndecan-4 signaling via NFAT regulates extracellular matrix production and cardiac myofibroblast differentiation in response to mechanical stress | |
| P478 | volume | 54 |
| Q36117802 | Acetylated α-Tubulin Regulated by N-Acetyl-Seryl-Aspartyl-Lysyl-Proline(Ac-SDKP) Exerts the Anti-fibrotic Effect in Rat Lung Fibrosis Induced by Silica |
| Q39137992 | Attenuated development of cardiac fibrosis in left ventricular pressure overload by SM16, an orally active inhibitor of ALK5. |
| Q36343041 | Biomechanics of Cardiac Function |
| Q35854107 | Ca2+-calcineurin signaling is involved in norepinephrine-induced cardiac fibroblasts activation |
| Q39050949 | Calcineurin signaling in the heart: The importance of time and place. |
| Q36850396 | Calreticulin regulates transforming growth factor-β-stimulated extracellular matrix production |
| Q58757982 | Cardiac fibrosis: new insights into the pathogenesis |
| Q34586808 | Contribution of syndecan-4 genetic variants to hypertension, the TAMRISK study |
| Q92689353 | Deletion of Calcineurin Promotes a Protumorigenic Fibroblast Phenotype |
| Q33823169 | Effects of Total Flavone from Rhododendron simsii Planch. Flower on Postischemic Cardiac Dysfunction and Cardiac Remodeling in Rats |
| Q38733315 | Epigenetic regulation of cardiac fibrosis |
| Q38302621 | Fell-Muir Lecture: Syndecans: from peripheral coreceptors to mainstream regulators of cell behaviour |
| Q38235819 | From stem cells to cardiomyocytes: the role of forces in cardiac maturation, aging, and disease. |
| Q34611013 | Increased expression of NF-AT3 and NF-AT4 in the atria correlates with procollagen I carboxyl terminal peptide and TGF-β1 levels in serum of patients with atrial fibrillation |
| Q55000702 | Increased passive stiffness promotes diastolic dysfunction despite improved Ca2+ handling during left ventricular concentric hypertrophy. |
| Q34540845 | Inhibitory effects of C-type natriuretic peptide on the differentiation of cardiac fibroblasts, and secretion of monocyte chemoattractant protein-1 and plasminogen activator inhibitor-1. |
| Q89606197 | Intracellular signaling dynamics and their role in coordinating tissue repair |
| Q37342086 | Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis |
| Q41229985 | Mechanical regulation of cardiac fibroblast profibrotic phenotypes. |
| Q38170412 | Mechanotransduction in the endothelium: role of membrane proteins and reactive oxygen species in sensing, transduction, and transmission of the signal with altered blood flow |
| Q27692541 | Myofibroblasts: trust your heart and let fate decide. |
| Q37242433 | Neuritin Up-regulates Kv4.2 α-Subunit of Potassium Channel Expression and Affects Neuronal Excitability by Regulating the Calcium-Calcineurin-NFATc4 Signaling Pathway |
| Q35437493 | PKC δ and βII regulate angiotensin II-mediated fibrosis through p38: a mechanism of RV fibrosis in pulmonary hypertension |
| Q41759666 | Pellino1-mediated TGF-β1 synthesis contributes to mechanical stress induced cardiac fibroblast activation |
| Q61809301 | Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity |
| Q41364227 | SIRT3 attenuates AngII-induced cardiac fibrosis by inhibiting myofibroblasts transdifferentiation via STAT3-NFATc2 pathway |
| Q48113692 | Serum-glucocorticoid-regulated kinase 1 contributes to mechanical stretch-induced inflammatory responses in cardiac fibroblasts. |
| Q40451749 | Shedding of syndecan-4 promotes immune cell recruitment and mitigates cardiac dysfunction after lipopolysaccharide challenge in mice. |
| Q41995058 | Skin infections are eliminated by cooperation of the fibrinolytic and innate immune systems. |
| Q41191530 | Soluble Epoxide Hydrolase Inhibition Protected against Angiotensin II-induced Adventitial Remodeling |
| Q37216988 | Syndecan 4 signaling is required for exercise-induced cardiac hypertrophy. |
| Q90633193 | Syndecan-4 Inhibits the Development of Pulmonary Fibrosis by Attenuating TGF-β Signaling |
| Q28554399 | Syndecan-4 Is an Independent Predictor of All-Cause as Well as Cardiovascular Mortality in Hemodialysis Patients |
| Q89449003 | Syndecan-4 Protects the Heart From the Profibrotic Effects of Thrombin-Cleaved Osteopontin |
| Q98771736 | Syndecan-4-/- Mice Have Smaller Muscle Fibers, Increased Akt/mTOR/S6K1 and Notch/HES-1 Pathways, and Alterations in Extracellular Matrix Components |
| Q41769628 | Syndecan-4: a component of the mechanosensory apparatus of cardiac fibroblasts. |
| Q38196176 | Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs. |
| Q36170775 | The Heparan Sulfate Proteoglycan Glypican-6 Is Upregulated in the Failing Heart, and Regulates Cardiomyocyte Growth through ERK1/2 Signaling |
| Q90233203 | The Non-Fibrillar Side of Fibrosis: Contribution of the Basement Membrane, Proteoglycans, and Glycoproteins to Myocardial Fibrosis |
| Q33737254 | The Soft- and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the Heart |
| Q64376796 | The extracellular matrix proteoglycan fibromodulin is upregulated in clinical and experimental heart failure and affects cardiac remodeling |
| Q37161329 | The pathogenesis of cardiac fibrosis. |
| Q38952244 | The role of cardiac fibroblasts in post-myocardial heart tissue repair |
| Q36609712 | Transcriptional control of cardiac fibroblast plasticity |
| Q28116181 | miR-18a-5p MicroRNA Increases Vascular Smooth Muscle Cell Differentiation by Downregulating Syndecan4 |